Does TACROLIMUS Cause Thrombotic microangiopathy? 1,982 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,982 reports of Thrombotic microangiopathy have been filed in association with TACROLIMUS (Tacrolimus). This represents 2.2% of all adverse event reports for TACROLIMUS.
1,982
Reports of Thrombotic microangiopathy with TACROLIMUS
2.2%
of all TACROLIMUS reports
307
Deaths
859
Hospitalizations
How Dangerous Is Thrombotic microangiopathy From TACROLIMUS?
Of the 1,982 reports, 307 (15.5%) resulted in death, 859 (43.3%) required hospitalization, and 184 (9.3%) were considered life-threatening.
Is Thrombotic microangiopathy Listed in the Official Label?
Yes, Thrombotic microangiopathy is listed as a known adverse reaction in the official FDA drug label for TACROLIMUS.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Thrombotic microangiopathy?
MYCOPHENOLATE MOFETIL (820)
CYCLOSPORINE (724)
GEMCITABINE (648)
ECULIZUMAB (636)
CYCLOPHOSPHAMIDE (602)
FLUDARABINE (480)
METHOTREXATE (447)
CARFILZOMIB (350)
METHYLPREDNISOLONE (345)
MELPHALAN (332)
Which TACROLIMUS Alternatives Have Lower Thrombotic microangiopathy Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB